COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis?

• Published in: Medical hypotheses Vol. 144; p. 110206
• Main Authors: Chaves Andrade, Marileia, Souza de Faria, Rodolfo, Avelino Mota Nobre, Sergio
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 01.11.2020
• Subjects: Brain - physiopathology; COVID-19 - immunology; COVID-19 - microbiology; COVID-19 - physiopathology; Dysbiosis - immunology; Dysbiosis - microbiology; Dysbiosis - physiopathology; Gastrointestinal Microbiome - immunology; Gastrointestinal Tract - immunology; Gastrointestinal Tract - microbiology; Homeostasis; Host Microbial Interactions - immunology; Host Microbial Interactions - physiology; Humans; Models, Biological; Neuroimmunomodulation - physiology; Pandemics; SARS-CoV-2 - immunology; SARS-CoV-2 - pathogenicity
• ISSN: 0306-9877; 1532-2777
• DOI: 10.1016/j.mehy.2020.110206

COVID-19 is associated with acute and lethal pneumonia, causing the severe acute respiratory syndrome (SARS), which is not confined to the respiratory tract, as demonstrated by clinical evidence of the involvement of multiple organs, including the central nervous system (CNS). In this context, we hypothesized that both oligosymptomatic and symptomatic patients present an imbalance in the microbiota-gut (immune system) and nervous system axis, worsening the clinical picture. The brain constantly receives a direct and indirect influence from the intestine, more specifically from the immune system and intestinal microbiota. The presence of SARS-CoV-2 in the intestine and CNS, can contribute to both neurological disorders and gut immune system imbalance, events potentialized by an intestinal microbiota dysbiosis, aggravating the patient’s condition and causing more prolonged harmful effects.